Clinical Case Report: Treatment of Central Serous Chorioretinopathy – from LIGHTMED
Brought to you by Lightmed
Lightmed’s clinical team shares this educational case report, including success stories from patients.
Click here to read the full report.
The LIGHTMED TruScan 577nm with SP-Mode® Microsecond Laser Technology is a safe and effective technology to treat
central serous retinopathy.
Early diagnosis and treatment is important in CSC in order to reduce the duration of SRD, and avoid degeneration of the RPE.
SP-Mode® Microsecond Laser Technology is used in the treatment of warming RPE cells, in order to lead to the “functional remodeling” of the RPE and the subsequent improvement of retinal function.
The yellow wavelength is well absorbed by the RPE melanin; and thus, it is suitable to treat RPE cells effciently.
Test irradiation is important for every patient because each person has a different extent of light absorption. Half of the visible threshold is a safe and effective parameter to treat CSC without scar formations.
SRF reduction varies among patients, and it is important to wait at least 3 months after treatment to notice SRF reduction.